Entellus Medical (ENTL) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Entellus Medical Announces First Quarter 2017 Financial Results
May 3, 2017 4:03 PM EDTPLYMOUTH, Minn., May 03, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ: ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today reported its financial results for the quarter ended March 31, 2017.Â
Recent Highlights and Accomplishments
Revenue of $19.1 million in the first quarter of 2017, an increase of 13% year-over-yearIn-office revenue represented 58% of U.S. product revenue in the first quarterReceived 510(k) clearance from the FDA and CE Mark for... More